Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2006
03/23/2006US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues
03/23/2006US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
03/23/2006US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain
03/23/2006US20060063776 heterocyclic amines such as 1-(4-Chloro-phenyl)-cyclobutyl]-{3-[4-(2-methoxy-phenyl)-piperazin-1-ylmethyl]-piperidin-1-yl}-methanone; used as dopamine, serotonin or norepinephrine transporters; addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity
03/23/2006US20060063769 Preventives/remedies for urinary disturbance
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006DE102004036349A1 Substituierte 3-Phenylpiperidin-Derivate Substituted 3-phenyl piperidine derivatives
03/23/2006CA2580601A1 Novel compounds useful for modulating abnormal cell proliferation
03/23/2006CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
03/22/2006EP1637141A1 Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease
03/22/2006EP1637140A1 Use of diphenylmethylpiperazine derivatives for the manufacture of a medicament for suppressing the proliferation of fibroblasts
03/22/2006EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636201A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase
03/22/2006EP1636200A2 Inhibitors of papilloma virus
03/22/2006EP1636186A1 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs)
03/22/2006EP1635828A1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
03/22/2006EP1399408B1 Method for producing (meth)acrylic acid esters
03/22/2006EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/22/2006CN1751038A Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof
03/22/2006CN1751023A Piperidine-benzenesulfonamide derivatives
03/22/2006CN1246312C Antihistaminic piperidine derivatives and intermediates for the preparation thereof
03/21/2006US7015320 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
03/21/2006US7015238 Crystalline organic acid salt of amlodipine
03/21/2006US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/21/2006CA2270887C Methods and compositions for inhibition of angiogenesis
03/21/2006CA2263983C Cyclic amine derivatives for inhibiting blood platelet aggregation
03/21/2006CA2129771C Phenylalkanolamine derivatives
03/21/2006CA2072416C Cyclopropenone derivatives
03/21/2006CA2043955C Pesticidal 1-arylpyrroles
03/16/2006WO2006028226A1 Novel imidazolidine derivative and use thereof
03/16/2006WO2006027252A1 Sigma receptor ligands
03/16/2006WO2006027135A1 4-aminomethyl benzamidine derivatives and their use as factor viiia inhibitors
03/16/2006WO2005115361A3 Androgen receptor modulators and method of treating disease using the same
03/16/2006WO2005113503A3 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
03/16/2006WO2005016884A9 Cyclopropyl derivatives as nk3 receptor antagonists
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
03/16/2006US20060058548 Process of preparing O-carbamoyl compounds in the presence of active amine group
03/16/2006US20060058530 Amidine substituted aryl aniline compounds
03/16/2006US20060058396 Amide compounds for the potentiation of cholinergic activity
03/16/2006US20060058352 Piperidine amine compounds and their use
03/16/2006US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof
03/16/2006US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
03/16/2006US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase
03/16/2006US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors
03/16/2006US20060058327 Mitotic kinesin inhibitors
03/16/2006US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide
03/16/2006CA2579886A1 Novel imidazolidine derivative and use thereof
03/16/2006CA2577610A1 Sigma receptor ligands
03/16/2006CA2577608A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
03/15/2006EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
03/15/2006EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
03/15/2006EP1633707A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists
03/15/2006EP1633703A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof
03/15/2006EP1633701A1 Benzamide nitrile derivatives
03/15/2006EP1633354A2 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes
03/15/2006EP1633336A2 Immunosuppressant compounds and compositions
03/15/2006EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006EP1359891B1 Primary intermediates for oxidative coloration of hair
03/15/2006EP0997147B1 Amino acid derivatives
03/15/2006CN1747931A Graftable hindered amine light stabilizers
03/15/2006CN1747929A Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
03/15/2006CN1245381C Phenylglycine derivatives
03/15/2006CN1245380C Anthranilic acid derivatives
03/14/2006US7012165 Oxidative fluorination of aromatic and chloroaromatic derivatives
03/14/2006US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/14/2006US7012083 For prophylaxis and therapy of pruritus
03/14/2006US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006CA2376091C Ethanesulfonyl-piperidine derivatives
03/14/2006CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
03/14/2006CA2308867C New substitute pyridine or piperidine compounds, their preparation process and the pharmaceutical compositions containing these compounds
03/14/2006CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
03/14/2006CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
03/09/2006WO2006026533A2 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors
03/09/2006WO2006025517A1 Sodium channel inhibitor
03/09/2006WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof
03/09/2006WO2006024778A1 Method for preparing n-aminopiperedine and its salts
03/09/2006WO2006024501A1 Alternative synthesis of renin inhibitors and intermediates thereof
03/09/2006WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
03/09/2006WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
03/09/2006US20060052615 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
03/09/2006US20060052611 Mitotic kinesin inhibitors
03/09/2006US20060052610 Piperidine derivatives and process for their production
03/09/2006US20060052608 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/09/2006US20060052606 Factor xa Inhibitors
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052445 Diarylsulfones as 5-HT2A antagonists
03/09/2006US20060052417 N3-((1-(2-Oxo-2-(phenylamino)ethyl)-4-piperidyl)methyl)- 1-(1-methylethyl)-1H-indazole-3-carboxamide; antiarthritic agents; rheumatic diseases; osteoarthritis; fibromyaleia;anticarcinogenic agents, pain; neuropathic pain; immunoincompetance; trauma; antiischemic agents; multiple sclerosis
03/09/2006US20060052413 Novel piperidine derivatives as modulators of chemokine receptor ccr5
03/09/2006US20060052408 Cyclopropyl compounds as ccr5 antagonists
03/09/2006US20060052396 Arylamines for the treatment of conditions associated with gsk-3
03/09/2006US20060052393 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
03/09/2006US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
03/09/2006US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
03/09/2006US20060052313 Selective dipeptide inhibitors of kallikrein
03/09/2006US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
03/09/2006US20060049061 electrooxidation reaction using 2-(N-pyrrolidine)-N,N,N-triethylethanammonium tetrafluoroborate or 3-N-piperidine-N,N,N-triethylammoniopropanesulphonamide tetrafluoroborate; proline final product
03/09/2006DE10231627B4 Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel Heterocyclic unsubstituted benzoyl ureas and their use as a medicament
03/09/2006CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof